Category: Sulphate

Laser Cataract Removal

Alstonine, Flavopereirine, Sempervirine, Serpentine, Pao Pereira, Rauwolfia, Ginko biloba & the Work of Mirko Beljanski

Alstonine, Flavopereirine, Sempervirine, Serpentine, Pao Pereira, Rauwolfia, Ginko biloba & the Work of Mirko Beljanski

For 40 years, the Yugoslavian molecular biologist, Mirko Beljanski PhD (1923–1998), in association with his wife and research associate, Monique, conducted research into the respective roles of DNA and RNA in the development and cure of cancer, first at the Pasteur Institute in France (1948–1978) and then at the Faculty of Pharmacy at Chatenay Malabry (1978–1988). During this time, he wrote 133 papers, published in both French and international journals.

Cancer is generally regarded as arising from damage to or mutations of the molecular structure of DNA. Beljanski’s primary thesis is that cancer is caused not only by DNA mutations but also by damage to the hydrogen bonds that hold the two strands of the DNA double helix together. Like a damaged zipper than is failing in places, allowing the two parts to separate, cancerous or pre-cancerous DNA has many broken or weakened hydrogen bonds. Once these bonds are broken over a particular area of the double helix, the DNA in that area is destabilized, and carcinogens are more readily able to infiltrate and cause the molecular damage that can lead to cancer. This explains, for example, why an excess of certain hormones such as estrogen and testosterone (and other steroids, too) is carcinogenic, although they do not appear to be the direct cause of mutations.

Among his other discoveries is that fragments of RNA (which he called Beljanski Leucocyte Restorers or BLBs) are capable of rapidly restoring the depletion of (red) blood platelets and (white) leucocytes brought about by radiation therapy and chemotherapy agents. BLBs selectively stimulate the normal replication of red and white blood cells in the bone marrow and spleen, without enhancing the proliferation of cancer cells. Beljanski reported that patients who received BLBs along with chemotherapy suffered few of the expected side effects, such as nausea and hair loss, and were able to continue with their normal daily lives.

Beljanski also developed what he called the ‘contest’ – a way of determining which kind of substances could destabilize DNA function, leading to cancerous cell proliferation, and, conversely, which kind of substances could repair or cause the programmed death (apoptosis) of damaged and cancer-forming DNA. Among such molecules, he discovered, are the naturally occurring plant alkaloids, also nine, flavopereirine, serpentine and sempervirine, which are able to distinguish between normal and cancer-forming DNA, either repairing the damaged DNA or causing the death of the malignant cells (apoptosis). Beljanski conducted many trials on the anti-cancer properties of these substances. He was able, for example, to cure an appreciable proportion of mice with lymphoma. Other in vitro studies showed that flavopereirine was active against a number of other cancer cell lines (brain, breast, ovarian, prostate, kidney, thyroid, pancreatic, colon, liver, skin), including those that were multidrug-resistant.

His research also showed that the flavanone, JO-1, which contains a large amount of naringin as well as some as yet unidentified substances, prevented the multiplication (in vitro) of human cancer cell lines (colon, ovary, breast, leukemia). Under the same experimental conditions, normal bone marrow cell multiplication was not affected. He also demonstrated that these substances also work in synergy with standard chemotherapy agents, providing better results than with the chemotherapy alone.

Dr Beljanski was forced to leave the Pasteur Institute when his innovative ideas came into conflict with the Institute’s new director. Underfunded, he continued his research and the publication of scientific papers, mostly in French. His wife, Monique, and daughter, Sylvia, now endeavor to bring the fruits of his research to a wider public. Sylvia Beljanski is president of Natural Source International Inc., in New York, the US company that now manufactures the Beljanski products.

Although he worked informally with many doctors in France and Belgium, Beljanski was largely ostracized by French oncologists. For a number of years prior to his death in 1998, he was persecuted as a charlatan, despite the commendations of many users of his products, including the French president, François Mitterand. In one instance, a journalist who had set out to expose Beljanski was not only unable to find any evidence of fraud, but ultimately became a grateful user of his products when he discovered that he himself had intestinal cancer. Beljanski’s work is the subject of a book, The Beljanski Anti-Cancer Remedies: Inside the Double Helix of DNA (2006).

The Beljanski products are now manufactured in the USA according to Beljanski’s methods. They have been shown to be totally non-toxic to animals and humans in the recommended doses:

Pao VAn extract of the bark of the Amazonian tree, Pao Pereira (Geissospermum vellosii), contains the alkaloid flavopereirine (also called PB-100). Flavopereirine is a smaller molecule than also nine, and is able to cross the blood-brain barrier, making it useful in the treatment of brain tumors. Research studies, many being in vitro, have shown flavopereirine to be effective
Hydrazine Sulphate

Hydrazine Sulphate

Hydrazine sulfate (or sulfate, in US spelling) is a commonly used, inexpensive industrial compound. Biologically, it inhibits a particular liver and kidney enzyme (a monoamine oxidase or MAO), thereby preventing cancer cells from obtaining glucose. This has been shown to inhibit cachexia (wasting), which is the immediate cause of death in over 70% of cancer cases. In a smaller number of cases, there is also some tumor regression. This enables some patients to overcome their cancer or live with it. This has been demonstrated in several clinical trials.

Research began in 1968 with an article suggesting that cachexia could be reduced by targeting a particular liver and kidney enzyme. Dr Joseph Gold of the Syracuse Cancer Research Institute of New York, who has pioneered the use of hydrazine sulfate as a cancer treatment, began testing rodents with hydrazine sulfate, getting rapid and positive results. The compound was then tested on human beings, with mixed results.

Like most cancer treatments, mainstream or complementary, hydrazine sulfate does not always work. There is also a long list of foods with which it interacts badly, and it should only be taken under medical supervision. Like other MAO inhibitors, it is incompatible with barbiturates, tranquilizers, alcohol, and other depressants of the central nervous system. Foods high in the amino acid, tyramine, such as mature cheeses and fermented foods should also be avoided.

Hydrazine sulfate has been the focus of considerable controversy in the cancer industry. Mainstream organizations refer to trials sponsored by the National Cancer Institute in the mid-1990s, which showed no benefit from its use. Critics have observed that these trials did not follow the correct procedures, since 94% of the patients were given tranquilizers, and were permitted the use of alcohol and barbiturates.

Annie Appleseed Project – An excellent introduction and overview, with some details of dosage, and which foods to avoid.

Diagnose Me – A useful overview.

Day Industries – Hydrazine Sulfate: The Real Story. A narrative overview.

Syracuse Cancer Research Institute – The charitable organization where Dr Joseph Gold works.

The Truth about Hydrazine Sulfate – Dr Joseph Gold tells his side of the story.

National Cancer Institute – A summary of hydrazine sulphate trials and other information from the viewpoint of the NCI.

National Institute of Health – A summary of the events in the political and trial history of hydrazine sulphate.

The Moss Reports – A review of trial data from before the publication of results from the NCI-sponsored trials.

Dr Burton Goldberg – “Holding the National Cancer Institute Accountable for Cancer Deaths.” An overview of some of the politics surrounding hydrazine sulphate.

Nu-gen Nutrition – A source of hydrazine sulphate from a US supplier of complementary cancer treatments.

Caesium Chloride– High pH Therapy

Caesium or cesium (US spelling) chloride is associated with the high pH (alkalinizing) therapeutic approach to cancer treatment. The theory that cancer cells are more susceptible than normal cells to high pH originated with the observation that certain areas of the world with a lower risk of cancer also had a higher soil concentration of alkali metals (especially potassium, cesium, and rubidium).

Researchers back in the 1920s first suggested cesium might be a useful anti-tumor agent. However, further studies in the 1930s showed no evidence for this. The high pH therapy for cancer was first advanced during the 1980s by Keith Brewer PhD, who published numerous papers and articles concerning the treatment, together with suggestions for further research. Dr Brewer was a physicist who felt that many of the findings of physics were relevant to biology, especially the physics of the cell membrane. He arrived at his therapeutic approach after considerable experimentation on cell membranes. Animal research studies confirming his theory, funded by Dr Brewer, were undertaken by Dr Marilyn Tufte of the Department of Biology at the University of Wisconsin at Platteville. A small number of uncontrolled human trials conducted by various physicians, especially Dr H.A. Nieper in Hannover, Germany, and Dr H.E. Sartori in Washington, DC, also showed significant positive results. As well as loss of pain within 12 to 24 hours, the treatment also resulted in rapid shrinkage of the tumor mass. However, Nieper and Sartori were also using vitamin B17, which in itself is regarded as a significant cancer treatment, so their results are not conclusive.

High pH therapy using caesium chloride therapy is usually given to patients with advanced metastatic cancer, for whom standard medicine can do no more. However, due to lack of sufficient research, there is no agreed dosage or treatment protocol. Generally, up to 6 to 9 gms per day (or sometimes more) of caesium chloride is administered in liquid form along with vitamins A and C, together with zinc and selenium supplements, which enhance the cellular uptake of caesium. Keith Brewer observes that there is some evidence …